AU8479498A - Dual specificity phosphatase and methods of use - Google Patents

Dual specificity phosphatase and methods of use

Info

Publication number
AU8479498A
AU8479498A AU84794/98A AU8479498A AU8479498A AU 8479498 A AU8479498 A AU 8479498A AU 84794/98 A AU84794/98 A AU 84794/98A AU 8479498 A AU8479498 A AU 8479498A AU 8479498 A AU8479498 A AU 8479498A
Authority
AU
Australia
Prior art keywords
methods
dual specificity
specificity phosphatase
phosphatase
dual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84794/98A
Inventor
Michael P. Myers
Nicholas K. Tonks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cold Spring Harbor Laboratory
Original Assignee
Cold Spring Harbor Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cold Spring Harbor Laboratory filed Critical Cold Spring Harbor Laboratory
Publication of AU8479498A publication Critical patent/AU8479498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU84794/98A 1997-07-08 1998-07-08 Dual specificity phosphatase and methods of use Abandoned AU8479498A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5190897P 1997-07-08 1997-07-08
US60051908 1997-07-08
US9098498P 1998-06-29 1998-06-29
US60090984 1998-06-29
PCT/US1998/014205 WO1999002704A2 (en) 1997-07-08 1998-07-08 Dual specifically phosphatase and methods of use

Publications (1)

Publication Number Publication Date
AU8479498A true AU8479498A (en) 1999-02-08

Family

ID=26729940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84794/98A Abandoned AU8479498A (en) 1997-07-08 1998-07-08 Dual specificity phosphatase and methods of use

Country Status (2)

Country Link
AU (1) AU8479498A (en)
WO (1) WO1999002704A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248327B1 (en) 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
WO2000060092A2 (en) * 1999-04-07 2000-10-12 Ceptyr, Inc. Dsp-3 dual-specificity phosphatase
US7078210B2 (en) 1999-07-02 2006-07-18 Ceptyr, Inc. DSP-3 dual-specificity phosphatase
AU4367600A (en) * 1999-07-02 2001-01-22 Ceptyr, Inc. Dsp-3 dual-specificity phosphatase
US6284538B1 (en) 1999-07-21 2001-09-04 Isis Pharmaceuticals, Inc. Antisense inhibition of PTEN expression
CA2377662A1 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders
EP1268818A2 (en) * 2000-03-24 2003-01-02 Millennium Pharmaceuticals, Inc. 18221, dual specificity phosphatase and uses thereof
EP1289472A4 (en) * 2000-05-30 2004-09-08 Advanced Res & Tech Inst Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
KR20040018598A (en) * 2002-08-23 2004-03-04 코웰창업투자(주) Tat-pten fusion protein and process for its preparation and its use
US20040106141A1 (en) * 2002-11-05 2004-06-03 The Regents Of The University Of California Methods and materials for examining pathways associated with glioblastoma progression
DE60331367D1 (en) 2002-12-30 2010-04-01 Angiotech Int Ag ACTIVE COMPOSITION OF FAST GELING POLYMERIC COMPOSITION
WO2004074459A2 (en) * 2003-02-19 2004-09-02 Georgetown University Pten-deficient cells and their uses
CN102666845B (en) * 2009-10-16 2015-06-10 不列颠哥伦比亚大学 Inhibitors of phosphatase and tensin homolog (PTEN) compositions, uses and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9611255A (en) * 1995-10-23 1999-12-28 Imp Cancer Research Thecnology nucleic acid, processes for determining a patient's susceptibility to cancer, for diagnosing cancer in a patient, for predicting the relative prospects for the particular appearance of cancer in a patient, for treating cancer and for determining the loss of heterozygosity in a tissue sample , system to detect the presence or absence of, or mutation, in the region of human chromosome 10, polypeptide, molecule and use of nucleic acid and a molecule.
US6262242B1 (en) * 1997-01-30 2001-07-17 Board Of Regents, The University Of Texas System Tumor suppressor designated TS10Q23.3
WO1998034624A1 (en) * 1997-02-07 1998-08-13 The Trustees Of Columbia University In The City Of New York Use of the p-ten suppressor gene in diagnosis and treatment of cancer

Also Published As

Publication number Publication date
WO1999002704A3 (en) 1999-04-01
WO1999002704A2 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU2644697A (en) Isolation of enzymes
AU3820597A (en) Phosphatase inhibitors and methods of use thereof
AU1498497A (en) Isolation and sequencing of the hazel FAD2-N gene
AU4583796A (en) Determination of software functionality
AU7171098A (en) Directed evolution of enzymes and antibodies
AU1616499A (en) Chemokine variants and methods of use
AU8479498A (en) Dual specificity phosphatase and methods of use
AU2749395A (en) Medical use of bromelain
AU8329498A (en) Diagnosis of edema
AU6585498A (en) Novel uncoupling protein and methods of use
AU9374298A (en) Preparation and use of biofilm-degrading, multiple-specificit y, hydrolytic enzyme mixtures
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU6303898A (en) Component of bromelain
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU3118297A (en) Sok-1 and methods of use
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7315996A (en) Improvements relating to the lining of pipelines and passageways
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU1451200A (en) Dual reporter system and methods of use therefor
AU1876695A (en) Phosphatase/phosphodiesterase enzyme inhibitors and methods
AU1570199A (en) Methods of lyophilizing solutions
AU4615497A (en) New forms of grip surfaces
AU1181897A (en) Medical use of proteases
AU8333998A (en) New use of nociceptin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase